RU2353356C2 - Применение производных ациламиноалкениленамида для лечения нарушений функциональной подвижности внутренних органов - Google Patents

Применение производных ациламиноалкениленамида для лечения нарушений функциональной подвижности внутренних органов Download PDF

Info

Publication number
RU2353356C2
RU2353356C2 RU2004127132/15A RU2004127132A RU2353356C2 RU 2353356 C2 RU2353356 C2 RU 2353356C2 RU 2004127132/15 A RU2004127132/15 A RU 2004127132/15A RU 2004127132 A RU2004127132 A RU 2004127132A RU 2353356 C2 RU2353356 C2 RU 2353356C2
Authority
RU
Russia
Prior art keywords
methyl
amino
bis
trifluoromethylbenzoyl
caprolactam
Prior art date
Application number
RU2004127132/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2004127132A (ru
Inventor
Джон Р. ФОЗАРД (FR)
Джон Р. ФОЗАРД
Эккхард ВЕБЕР (CH)
Эккхард ВЕБЕР
Ханс-Юрген ПФАННКУХЕ (DE)
Ханс-Юрген ПФАННКУХЕ
Original Assignee
Новартис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Новартис Аг filed Critical Новартис Аг
Publication of RU2004127132A publication Critical patent/RU2004127132A/ru
Application granted granted Critical
Publication of RU2353356C2 publication Critical patent/RU2353356C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
RU2004127132/15A 2002-02-08 2003-02-07 Применение производных ациламиноалкениленамида для лечения нарушений функциональной подвижности внутренних органов RU2353356C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0203061.7A GB0203061D0 (en) 2002-02-08 2002-02-08 Organic compounds
GB0203061.7 2002-02-08

Publications (2)

Publication Number Publication Date
RU2004127132A RU2004127132A (ru) 2005-06-10
RU2353356C2 true RU2353356C2 (ru) 2009-04-27

Family

ID=9930743

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004127132/15A RU2353356C2 (ru) 2002-02-08 2003-02-07 Применение производных ациламиноалкениленамида для лечения нарушений функциональной подвижности внутренних органов

Country Status (18)

Country Link
US (2) US20050203164A1 (https=)
EP (2) EP1476167A1 (https=)
JP (2) JP2005516994A (https=)
KR (2) KR20100100994A (https=)
CN (1) CN1301714C (https=)
AU (1) AU2003244446B2 (https=)
BR (1) BR0307479A (https=)
CA (1) CA2471964A1 (https=)
GB (1) GB0203061D0 (https=)
IL (2) IL162816A0 (https=)
MX (1) MXPA04007640A (https=)
NO (1) NO20043735L (https=)
NZ (1) NZ534231A (https=)
PL (1) PL370255A1 (https=)
RU (1) RU2353356C2 (https=)
TW (1) TWI330177B (https=)
WO (1) WO2003066062A1 (https=)
ZA (1) ZA200404960B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds
EP1686985A2 (en) 2003-10-27 2006-08-09 Novartis AG Use of neurokinin antagonists in the treatment of urinary incontinence
CN101568331A (zh) 2006-09-08 2009-10-28 奥尔制药有限公司 减少或缓解消化道炎症的方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5929067A (en) * 1995-02-22 1999-07-27 Novartis Ag 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
RU2161894C1 (ru) * 1999-08-10 2001-01-20 НИФ "Ультрасан" Лечебно-профилактическая композиция
US6319917B1 (en) * 1996-08-22 2001-11-20 Novartis Ag Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217996A (en) * 1992-01-22 1993-06-08 Ciba-Geigy Corporation Biaryl substituted 4-amino-butyric acid amides
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
GB9525296D0 (en) * 1995-12-11 1996-02-07 Merck Sharp & Dohme Therapeutic agents
GB9708484D0 (en) * 1997-04-25 1997-06-18 Merck Sharp & Dohme Therapeutic agents
PL191496B1 (pl) * 1997-07-02 2006-05-31 Merck & Co Inc Odmiana polimorficzna 2-(R)-{1-(R) -[3,5-bis(trifluorometylo)-fenylo]etoksy} -3-(S)-(4-fluoro) fenylo-4-[3-(5-okso-1H,4H-1,2,4-triazolo)metylo] morfoliny, sposób jej wytwarzania, zawierająca ją kompozycja farmaceutyczna i jej zastosowanie
TW520370B (en) * 1998-11-20 2003-02-11 Meiji Seika Kaisha Benzooxazole derivatives and a pharmaceutical composition containing the derivatives as an active ingredient
GB0010958D0 (en) 2000-05-05 2000-06-28 Novartis Ag Organic compounds
US20040058914A1 (en) * 2000-12-22 2004-03-25 Takayuki Doi Combination drugs
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5929067A (en) * 1995-02-22 1999-07-27 Novartis Ag 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
US6319917B1 (en) * 1996-08-22 2001-11-20 Novartis Ag Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists
RU2161894C1 (ru) * 1999-08-10 2001-01-20 НИФ "Ультрасан" Лечебно-профилактическая композиция

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Беликов В.Г. Фармацевтическая химия. - М.: Высшая школа, 1993, т.1, с.43-47. *

Also Published As

Publication number Publication date
KR20040081492A (ko) 2004-09-21
US20070293473A1 (en) 2007-12-20
GB0203061D0 (en) 2002-03-27
EP2216025A3 (en) 2010-11-10
JP2005516994A (ja) 2005-06-09
EP2216025A2 (en) 2010-08-11
KR20100100994A (ko) 2010-09-15
ZA200404960B (en) 2006-05-31
TWI330177B (en) 2010-09-11
NO20043735L (no) 2004-09-07
PL370255A1 (en) 2005-05-16
EP1476167A1 (en) 2004-11-17
MXPA04007640A (es) 2004-11-10
JP2010241835A (ja) 2010-10-28
IL162816A (en) 2010-11-30
RU2004127132A (ru) 2005-06-10
US20050203164A1 (en) 2005-09-15
WO2003066062A1 (en) 2003-08-14
AU2003244446A1 (en) 2003-09-02
TW200302818A (en) 2003-08-16
AU2003244446B2 (en) 2006-08-10
CA2471964A1 (en) 2003-08-14
CN1301714C (zh) 2007-02-28
HK1077749A1 (en) 2006-02-24
BR0307479A (pt) 2004-12-07
IL162816A0 (en) 2005-11-20
NZ534231A (en) 2007-02-23
CN1627947A (zh) 2005-06-15

Similar Documents

Publication Publication Date Title
ES2338102T3 (es) Derivados de 3-amido-1,2-benzoisoxazol, procedimiento para su preparacion y su empleo.
OA12631A (fr) Amides d'acide anthranilique avec une chaîne latérale hétéroarylsulfonyle, procédé our leur préparation, leur utilisation comme médeicament ou comme agent de diagnostic et préparations pharmaceutiquescontenant lesdits composés.
HUP0303624A2 (hu) NEP inhibitor hatású N-fenpropil-ciklopentil-csoporttal szubsztituált glutáramid származékok és ezeket tartalmazó gyógyászati készítmények és eljárás a vegyületek előállítására
CN104662007A (zh) 胱硫醚-γ-裂合酶(CSE)抑制剂
CN1243507A (zh) 用作mmp抑制剂的双磺酰胺异羟肟酸类化合物
CN103200942A (zh) [3-(1-(1h-咪唑-4-基)乙基)-2-甲基苯基]甲醇的酯前药
JP2006500399A (ja) ナトリウムチャンネルブロッカーとしての、アリール−結合−アリール置換された、チアゾリジン−ジオンおよびオキサゾリジン−ジオン
RU2353356C2 (ru) Применение производных ациламиноалкениленамида для лечения нарушений функциональной подвижности внутренних органов
JP2026504208A (ja) ベンゾイソチアゾール化合物、その医薬組成物および用途
TWI721697B (zh) 用於治療骨關節炎的化合物
WO2016165014A1 (en) Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereof
JP2002338471A (ja) 勃起機能不全のための治療薬
DE60308166T2 (de) Dipeptidische wachstumshormonsekretionsförderern
CN101282940B (zh) 含氟化合物
HK1145139A (en) Use of acylaminoalkenylene-amide derivatives in irritable bowel syndrome and functional dyspepsia
JP3112356B2 (ja) シクロペンテノン化合物及び該化合物を有効成分とする脳機能改善薬
HK1077749B (en) Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera
JP2004155661A (ja) 突然死予防剤
JP4096363B2 (ja) 鼻又は眼の充血治療剤
HK40122467A (zh) 一种酞嗪酮类化合物及其制备方法、药物组合物及用途
WO2004063201A1 (ja) 統合失調症治療剤
EA011091B1 (ru) Производные пиразолопиримидинтиона, их соли и сольваты, способы их получения и использования
JPH11246436A (ja) 結合組織疾患治療薬およびペプチド誘導体
JP2003113084A (ja) 肺高血圧症の治療及び／または予防薬
CN1874766A (zh) 神经激肽拮抗剂在尿失禁治疗中的用途

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20090208

MM4A The patent is invalid due to non-payment of fees

Effective date: 20120208